Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases

British Journal of Surgery

Volumn 97, Issue 9, 2010, Pages 1354-1362

  Karoui, M ^b   Vigano, L ^b   Goyer, P ^b   Ferrero, A ^b   Luciani, A ^a   Aglietta, M ^c   Delbaldo, C ^b   Cirillo, S ^c   Capussotti, L ^c   Cherqui, D ^b  

^a Department of Radiology ^*  (Italy)

^b HENRI MONDOR HOSPITAL   (France)

^c MAURIZIANO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; EVALUATION; FEASIBILITY STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIGATION; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PORTAL VEIN; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIGATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956401178     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7128     Document Type: Conference Paper

References (35)

1. Manfredi S, Lepage C, Hateni C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254-259.
2. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston Gj, Rces M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. BrJ Cancer 2006; 94: 982-999.
3. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a. planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777-785.
4. JaeckD, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-1049.
5. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 2007; 11: 1498-1504.
6. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 2007; 33:329-335.
7. Pamecha V, Nedjat-Shokouhi B, Gurusamy K, Glantzounis GK, Sharma D, Davidson BR. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg 2008; 25: 387-393.
8. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 2008; 248: 994-1005.
9. Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk. A, Meiler J et al. Two-stage hepatectomy (RO) with portal vein ligation - towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis 2009; 24: 409-418.
10. Thelen A, Jonas S, Bcnckert C, Spinelli A, Lopez-Hänninen E, Rudolph B et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. IntJ Colorectal Dis 2007; 22: 1269-1276.
11. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis.AnnSurg Oncol 2007; 14: 3481-3491.
12. Muratore A, Zorzi D, Bouzari H, Amisano M, Massucco P, Sperti E et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007; 14: 766-770.
13. Karoui M, Charachon A, Delbaldo C, Loriau J, Laurent A, Sobhani I et al. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 2007; 142: 619-623.
14. Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 2007; 31: 1643-1651.
15. Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, Regge D et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 2008; 143: 978-982.
16. Malassagne B, Cherqui D, Alon R, Brunetti F, Humeres R, Fagniez PL. Safety of selective vascular clamping for major hepatectomies. JAm Coll Surg 1998; 187: 482-486.
17. Cherqui D, Malassagne B, Colau PI, Brunetti F, Rotman N, Fagniez PL. Hepatic vascular exclusion with preservation of the cavai flow for liver resections. Ann Surg 1999; 230: 24-30.
18. Capussotti L, Ferrero A, Viganò L, Ribero D, Lo Tesoriere R, Polastri R. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 2007; 14: 195-201.
19. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D et al. The '50-50 criteria.' on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242: 824-828.
20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
21. Vibert E, Bretagnol F, Alves A, Pocard M, Valleur P, Panis Y. Multivariate analysis of predictive factors for early postoperative death after colorectal surgery in patients with colorectal cancer and synchronous unresectable liver metastases. Dis Colon Rectum 2007; 50: 1776-1782.
22. Eisenberger A, Whelan RL, Neugut AI. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a. review. IntJ Colorectal Dis 2008; 23: 559-568.
23. Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-1835.
24. Galizia. G, Lieto E, Orditura M, Castellano P, Imperatore V, Pinto M et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008; 143:352-358.
25. Evans MD, Escofet X, Karandikar SS, StamatakisJD. Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer. World J Surg Oncol 2009; 7: 28.
26. Mahteme H, Pa°hlman L, Glimelius B, Graf W. Prognosis after surgery in patients with incurable rectal cancer: a population-based study. Br J Surg 1996; 83: 1116-1120.
27. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12: 297-303.
28. Karoui M, Penna. C, Amin-Hashem M, Mitry E, Benoist S, Franc B et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7.
29. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006; 93: 872-878.
30. Benoist S, Brouquet A, Penna. C, Julie C, El Hajjam M, Chagnon S et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006;24:3939-3945.
31. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-1047.
32. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a. randomized GERCOR study. J Clin Orarol 2004; 22: 229-237.
33. Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, Herbst F et al. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 2008; 26: 1830-1835.
34. Van Cutsem E, Könne CH, Hitre E Zaluski J, Chang Chien CR, Makhson A et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360: 1408-1417.
35. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. Rl resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 2008; 248: 626-637.